Our world is in a constant state of evolution, with advanced technologies and digitalisation reshaping the landscape. Implementing AI and Cloud technology raises important questions about how they will impact the regulation of pharmaceutical products. Are pharmaceutical companies prepared for this new era?
The 4th Annual Pharmaceutical Regulatory Affairs Summit has been meticulously crafted to comprehensively address the pressing issues in Regulatory Affairs, including the transformative impact of digitalisation and AI. In addition, our event will spotlight the following hot themes: patient-centeredness, fostering innovation, and navigating the 'adjustments to EU Pharmaceutical Strategy' and many others.
Take the opportunity to network with senior-level decision-makers, share your ideas, gain crucial insights, and get inspired by the future of pharmaceutical regulation. Join us to learn, implement, and benefit from the remarkable developments in this dynamic industry!
Members of board, C-level, Senior/Global Vice Presidents, Directors, Heads of departments from pharmaceutical industry involved in: